Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Evaluating brentuximab vedotin for elderly patients with hard to treat Hodgkin lymphoma

Posted by on Mar 24, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) in elderly patients with relapsed or unresponsive Hodgkin lymphoma (HL). This study found that this treatment was effective, although frail patients may be at higher risk for side effects. Some background Most patients with HL respond to front-line...

Read More

Reviewing treatment options for patients with recurrent classical Hodgkin’s lymphoma

Posted by on Mar 16, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviews treatment options for patients with classical Hodgkin's lymphoma (cHL) that came back (relapsed) after chemotherapy. This study found that targeted therapies are becoming more prevalent and that patient outcomes have improved. Some background cHL is a cancer of white blood cells called lymphocytes....

Read More

Have outcomes improved for patients with Hodgkin’s lymphoma who relapse after a stem cell transplant?

Posted by on Mar 16, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the long-term outcomes of patients with classical Hodgkin’s lymphoma (cHL) that came back after an autologous stem cell transplant (autoSCT). This study found that advancements in treatment have helped improve survival outcomes for patients. Some background Chemotherapy is usually the first-line...

Read More

Evaluating brentuximab vedotin plus bendamustine for patients with hard-to-treat classical Hodgkin lymphoma

Posted by on Mar 8, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the effectiveness of brentuximab vedotin (Adcetris) plus bendamustine (Treanda) for patients with hard to treat classical Hodgkin lymphoma (cHL). This study found that this regimen is an effective salvage therapy for these patients. Some background Standard first-line chemotherapy is highly effective in treating...

Read More

Does omitting radiotherapy improve outcomes for patients with early-stage Hodgkin lymphoma?

Posted by on Mar 3, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the outcomes of removing radiotherapy from treatment for patients with early-stage Hodgkin lymphoma (HL). This study concluded that radiotherapy improved survival without disease progression for patients while omitting it did not affect overall survival. Some background Chemotherapy followed by radiotherapy (RT)...

Read More

Can a stem cell transplant improve outcomes of patients with cHL after nivolumab treatment?

Posted by on Feb 29, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the outcomes of a stem cell transplant after nivolumab (Opdivo) therapy in patients with classical Hodgkin’s lymphoma (cHL) that came back or stopped responding to treatment. This study concluded that nivolumab followed by stem cell transplant is safe and effective for these patients. Some background...

Read More

Reviewing outcomes for children and adolescents with Hodgkin’s lymphoma

Posted by on Feb 23, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed treatments and outcomes for children and adolescents with Hodgkin’s lymphoma (HL). The authors found that chemotherapy alone was a common treatment and that outcomes have improved for these young patients. Some background Hodgkin’s lymphoma (HL) is a cancer of the white blood cells. It can affect both...

Read More

Comparing different sources for stem cell transplantation for patients with lymphoma

Posted by on Feb 20, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the outcomes of patients with lymphoma who had an allogeneic stem cell transplant with different sources of stem cells. This study found that stem cells from a matching donor had better outcomes compared to those from unrelated cord blood. Some background Allogeneic stem cell transplantation is one type of stem...

Read More

Evaluating stem cell transplant outcomes for patients classical Hodgkin’s lymphoma

Posted by on Feb 16, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study looked at the outcomes of autologous stem cell transplantation (ASCT) to treat recurrent classical Hodgkin’s lymphoma (cHL). This study concluded that ASCT is effective, with patients who responded after the transplant having the best outcomes. Some background cHL is usually treated with chemotherapy and...

Read More

How useful is PET scanning during treatment for patients with newly diagnosed Hodgkin lymphoma?

Posted by on Feb 11, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed the importance of PET scanning during treatment for patients with Hodgkin lymphoma (HL). Some background PET scanning during treatment (interim PET) is used to guide therapy for patients with newly diagnosed HL. Depending on the scan results, treatment can be decreased, increased, or changed to a different...

Read More